U.S. Preventive Services Task Force. (2008). Screening for prostate cancer: U.S. Preventive Services Task Force Recommendation Statement. Annals of Internal Medicine, 149(3), 185-191.
Vainio, H., and Bianchini, F. (2002). Breast Cancer Screening. IARC Handbooks of Cancer Prevention, Vol. 7. Lyon, France: International Agency for Research on Cancer Press and World Health Organization.
Vercelli, M., Quaglia, A., Marani, E., and Parodi, S. (2000). Prostate cancer incidence and mortality trends among elderly and adult Europeans. Critical Reviews in Oncology/ Hematology, 35, 133-144.
Verdecchia, A., Francisci, S., Brenner, H., Gatta, G., et al. (2007). Recent cancer survival in Europe: A 2000-2002 period analysis of EUROCARE-4 data. Lancet Oncology, 8, 784-796.
Veronesi, U., Cascinelli, N., Mariani, L., Greco, M., et al. (2002). Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. New England Journal of Medicine, 347(16), 1227-1232.
Veronesi, U., Boyle, P., Goldhirsch, A., Orecchia, R., et al. (2005). Breast cancer. Lancet, 365, 1727-1741.
Vutuc, C., Haidinger, G., and Waldhoer, T. (1998). Prevalence of self-reported screening mammography and impact on breast cancer mortality in Austria. Wien Klin Wsch, 110, 485-490.
Wells, J. (1998). Mammography and the politics of randomised controlled trials. British Medical Journal, 317(31), 1224-1230.
Wilt, T.J., MacDonald, R., Rutks, I., Shamliyan, T.A., et al. (2008). Systematic review: Comparative effectiveness and harms of treatments for clinically localized prostate cancer. Annals of Internal Medicine, 148(6), 435-448.
Wolf-Maier, K., Cooper, R., Kramer, H., Banegas, J., Giampaoli, S., Joffres, M., Poulter, N., Primastesta, P., Stegmayr, B., and Thamm, M. (2004). Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension, 43(10), 10-17.
Wong, Y.-N., Mitra, N., Hudes, G., Localio, R., et al. (2006). Survival associated with treatment vs. observation of localized prostate cancer in elderly men. Journal of the American Medical Association, 296, 2683-2693.
Wood, W.C. (1994). Progress from clinical trials on breast cancer. Cancer, 74(S9), 2606-2609.
World Health Organization. (2009). World Health Organization Statistical Information System. Available: http://www.who.int/whosis/whostat/en/ [accessed May 2010].
Writing Group for the Women’s Health Initiative Investigators. (2002). Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women’s Health Initiative randomized controlled trial. Journal of the American Medical Association, 288, 321-333
Zappa, M., Visioli, C., Crocetti, E., Buonamici, C., Baccini, A., Taddei, S., and Ciatto, S. (2003). Practice of opportunistic PSA screening in the Florence District. Cancer Prevention, 12, 201-204.
Zhou, E.H., Ellis, R.J., Cherullo, E., Colussi, V., et al. (2009). Radiotherapy and survival in prostate cancer patients: A population-based study. International Journal of Radiation Oncology*Biology*Physics, 73(1), 15-23.